| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 05/12/2005 | WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 05/12/2005 | WO2005001979A3 Fluorinated sulfonamide compounds and polymer electrolyte membranes pepared therefrom for use in electrochemical cells |
| 05/11/2005 | EP1529045A2 New compounds |
| 05/11/2005 | EP1528919A2 Therapeutic use of aryl amino acid derivatives |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |
| 05/06/2005 | WO2005040157A2 Novel mch receptor antagonists |
| 05/06/2005 | WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 05/06/2005 | WO2005040127A1 Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2542220A1 Novel mch receptor antagonists |
| 05/04/2005 | EP1528611A2 White light-emitting compound, process for producing the same and luminescent element utilizing the same |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | CN1612868A Ethylene derivative and use as phophatidase |
| 05/04/2005 | CN1199957C 'Sqiqu site' derivative and its preparing method as well as its activity of anti asthma |
| 05/04/2005 | CN1199956C Oxadiazole derivs. having anticancer effects |
| 05/03/2005 | US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050089719 fluorescent compound capable of emitting white light at high purity |
| 04/27/2005 | EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085549 Hetrocyclic aryl sulphonamides |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085523 Imidazolyl and pyrazolyl ethyne compounds |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/20/2005 | EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 04/14/2005 | WO2005032550A2 Peptide deformylase inhibitors |
| 04/14/2005 | WO2005032465A2 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 04/14/2005 | WO2005017126A3 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/14/2005 | WO2005012241A3 p-38 KINASE INHIBITORS |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | CA2539438A1 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
| 04/07/2005 | WO2005030780A1 Fluorescent labeled sphingosines |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005030695A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 04/07/2005 | WO2005030203A1 Substituted oxadiazolidinediones als pai-1 inhibitors |
| 04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
| 04/07/2005 | US20050075345 1,2,4-Oxadiazoline-5-one or thiazolidine-2,4-dione derivatives; hypertensive, antiinflammatory, antiallergen, antiischemic, antihistamine, bronchodilator, and anticarcinogenic agents; cardiovascular, skin, gastrointestinal, and respiratory system disorders; cyclization, catalytic hydrogenation |
| 04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | CA2538671A1 Substituted oxadiazolidinediones als pai-1 inhibitors |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875782 Antidiabetic agents, dietetics, anticancer agents |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/30/2005 | EP1517975A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515709A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 03/22/2005 | US6869454 Dyeing agents for keratin fibers, especially human hair |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023787A1 Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity |
| 03/17/2005 | US20050056811 Liquid crystalline compound, liquid crystalline composition and retardation film |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/16/2005 | CN1596295A 1, 3, 4-oxadiazole additives for lubricants |
| 03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
| 03/10/2005 | WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/08/2005 | US6863841 Light emitting diodes; thin films transistors |
| 03/03/2005 | WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | WO2005000298A3 5-membered heterocycle-based p-38 inhibitors |
| 03/03/2005 | CA2536253A1 Aminofurazan compounds useful as protein kinase inhibitors |
| 03/02/2005 | EP1509509A1 Glucagon antagonists/inverse agonists |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 02/24/2005 | WO2005017126A2 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 02/24/2005 | WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585756A Substituted diphenyl heterocycles useful for treating HCV infection |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |